← Open Payments lookup

MEAGAN PICKETT: Open Payments

NPI 1770295735 · KOSCIUSKO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$465 in 23 payments from 8 companies in 2025. Trend: 2023 $519 · 2024 $1,122 · 2025 $465

Food & beverage: $465
CompanyPaymentsAmount
Paratek Pharmaceuticals, Inc.8$218
ABBVIE INC.5$79
Novo Nordisk Inc3$51
AstraZeneca Pharmaceuticals LP2$34
GlaxoSmithKline, LLC.2$30
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$24
Bayer Healthcare Pharmaceuticals Inc.1$14
Sumitomo Pharma America, Inc.1$14

Products named: NUZYRA, Ozempic, UBRELVY, TRELEGY ELLIPTA, CAPLYTA, AIRSUPRA, BREZTRI, CREON.

Industry payments across MS — which companies pay providers there.